• Buy 1 Get 1 FREE for immortalized cells| limited time until end of June

  • Boost Your Research with FREE Freezing Medium

Primary Cells

Human Mobilized Peripheral Blood CD56+ NK Cells

  • For research use only

Cat No.

ABC-TC3899

Product Type

Immune Cells

Cell Type

NK Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Storage

Liquid Nitrogen

Human Mobilized Peripheral Blood CD56+ NK Cells from AcceGen, positively selected immune cells for cytotoxicity, immunology, and translational studies.

Product Image

Description

Human Mobilized Peripheral Blood CD56+ NK Cells are lymphocytes isolated from mobilized peripheral blood mononuclear cells using immunomagnetic CD56 Micro-Beads. CD56+ NK cells play critical roles in immune surveillance, directly lysing virally infected or malignant cells via antibody-dependent cellular cytotoxicity (ADCC) and cytokine secretion. They also modulate adaptive immunity by interacting with dendritic cells and T cells. Defective NK activity contributes to viral persistence and impaired tumor surveillance. Key surface markers include CD56. To ensure the quality of these primary cells, repeated freeze-thaw cycles are not recommended due to the fragile nature of these cells. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

Human Mobilized Peripheral Blood CD56+ NK Cells, Mobilized NK Cells, CD56+ Natural Killer Cells, mPB NK Cells

Species

Human

Cat.No

ABC-TC3899

Product Category

Primary Cells

Size/Quantity

1 vial

Cell Type

NK Cell

Growth Mode

Suspension

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Peripheral Blood

Disease

Normal

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Immune Cells

Quality Control

All cells test negative for mycoplasma, bacteria, yeast, and fungi.

Application

  • Human Mobilized Peripheral Blood CD56+ NK Cells have significant therapeutic potential, particularly in cancer immunotherapy and infectious disease treatment. Due to their innate ability to recognize and kill malignant or virus-infected cells without prior sensitization, they are being explored in adoptive cell therapy (ACT) for hematological malignancies and solid tumors.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring Human Mobilized Peripheral Blood CD56+ NK Cells

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button